申请人:Blench Toby Jonathan
                            
                            
                                公开号:US20120202788A1
                            
                            
                                公开(公告)日:2012-08-09
                            
                            Provided are compounds of Formula I, stereoisomers, tautomers, solvates, prodrugs and pharmaceutically acceptable salts thereof, wherein A, X, R
1
, R
2
, R
4
and R
5
are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, and methods of manufacturing a compound of Formula I.
                            提供了公式I的化合物,立体异构体,互变异构体,溶剂化物,前药和药学上可接受的盐,其中A,X,R1,R2,R4和R5在此定义,以及包括公式I的化合物和药学上可接受的载体,辅料或载体的制药组合物,使用该化合物或组合物进行治疗的方法,以及制造公式I的化合物的方法。